Found: 4
Select item for more details and to access through your institution.
Evolution of Humoral and Cellular Immunity Post–Breakthrough Coronavirus Disease 2019 in Vaccinated Patients With Hematologic Malignancy Receiving Tixagevimab-Cilgavimab.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 11, p. 1, doi. 10.1093/ofid/ofad550
- By:
- Publication type:
- Article
High Rates of Seroprotection and Seroconversion to Vaccine-Preventable Infections in the Early Post–Autologous Stem Cell Transplant Period.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 10, p. 1, doi. 10.1093/ofid/ofad497
- By:
- Publication type:
- Article
Prospective comprehensive profiling of immune responses to COVID‐19 vaccination in patients on zanubrutinib therapy.
- Published in:
- EJHaem, 2023, v. 4, n. 1, p. 216, doi. 10.1002/jha2.639
- By:
- Publication type:
- Article
Costs associated with invasive Scedosporium and Lomentospora prolificans infections: a case-control study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 1, p. 46, doi. 10.1093/jac/dkad345
- By:
- Publication type:
- Article